menu
    • menu

    Company profile for Oxular

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness. Strategic focus The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by: rising prevalence of retinal disease due to aging pop...
    Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness. Strategic focus The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by: rising prevalence of retinal disease due to aging populations and the increasing incidence of diabetes; approval of new and longer lasting treatments; better drug delivery; & better access to healthcare globally Oxular’s development pipeline includes treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oxularunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Magdalen Centre, 1 Robert Robinson Avenue, Oxford OX4 4GA
    Telephone
    Telephone
    +44 (0)1865 636200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oxular.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oxular-limited
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regeneron snaps up eye biotech, snaring science but not staff
    Regeneron snaps up eye biotech, snaring science but not staff

    02 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/regeneron-acquires-uk-biotech-adding-oxulars-eye-disease-delivery-tech-portfolio

    FIERCE BIOTECH
    02 Jan 2025
    Share Share
    Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer
    Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer

    07 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221107005193/en

    BUSINESSWIRE
    07 Nov 2022
    Share Share
    Oxular appoints Dr. Friedrich Asmus as Chief Medical Officer
    Oxular appoints Dr. Friedrich Asmus as Chief Medical Officer

    07 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/oxular-appoints-dr-friedrich-asmus-as-chief-medical-officer-301306665.html

    PRNEWSWIRE
    07 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search